Skip to content

Development of Generic Drug Products Under Suitability Petition


    🔔 Note: Stop playback at 57:43 to complete this lesson.


    Presenter

    Heather Boyce, PhD
    Lead Pharmacokineticist
    Division of Therapeutic Performance II (DTP II)
    Office of Research and Standards (ORS)
    Office of Generic Drugs (OGD)
    Center for Drug Evaluation and Research (CDER)
    US Food and Drug Administration (FDA)

    Leave a Comment

    Your email address will not be published. Required fields are marked *